Genetic study of diabetic retinopathy: recruitment methodology and analysis of baseline characteristics

Diabetic retinopathy (DR) is a blinding disease of increasing prevalence that is caused by a complex interplay of genetic and environmental factors. Here we describe the patient recruitment methodology, case and control definitions, and clinical characteristics of a study sample to be used for genome‐wide association analysis to detect genetic risk variants of DR.

[1]  R. Klein,et al.  Genome-wide association study in a Chinese population with diabetic retinopathy. , 2013, Human molecular genetics.

[2]  T. Hansen,et al.  What Is the Contribution of Two Genetic Variants Regulating VEGF Levels to Type 2 Diabetes Risk and to Microvascular Complications? , 2013, PloS one.

[3]  S. Tiefenbrun.  STARR COUNTY (Texas) , 2012 .

[4]  M. Daly,et al.  Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). , 2011, Investigative ophthalmology & visual science.

[5]  M. Brown,et al.  Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1 , 2011, Nature Genetics.

[6]  D. Altshuler,et al.  Power in the phenotypic extremes: a simulation study of power in discovery and replication of rare variants , 2011, Genetic epidemiology.

[7]  F. Tsai,et al.  Genome-wide association study of diabetic retinopathy in a Taiwanese population. , 2011, Ophthalmology.

[8]  Francesco Bandello,et al.  The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. , 2011, Ophthalmology.

[9]  D. Nicolae,et al.  Genome-wide meta-analysis for severe diabetic retinopathy. , 2011, Human molecular genetics.

[10]  R. Klein,et al.  Identification of Diabetic Retinopathy Genes through a Genome-Wide Association Study among Mexican-Americans from Starr County, Texas , 2010, Journal of ophthalmology.

[11]  T. Peto,et al.  A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. , 2010, Ophthalmology.

[12]  J. Craig,et al.  Prevalence and associations of diabetic retinopathy in indigenous Australians within central Australia: the Central Australian Ocular Health Study , 2010, Clinical & experimental ophthalmology.

[13]  N. Petrovsky,et al.  Aldose Reductase Gene Polymorphisms and Diabetic Retinopathy Susceptibility , 2010, Diabetes Care.

[14]  Jing Xie,et al.  The prevalence and causes of vision loss in Indigenous Australians: the National Indigenous Eye Health Survey , 2010, The Medical journal of Australia.

[15]  A. Hewitt,et al.  A Systematic Meta-Analysis of Genetic Association Studies for Diabetic Retinopathy , 2009, Diabetes.

[16]  R. Elston,et al.  Heritability of the severity of diabetic retinopathy: the FIND-Eye study. , 2008, Investigative ophthalmology & visual science.

[17]  B. Klein,et al.  Overview of epidemiologic studies of diabetic retinopathy. , 2007, Ophthalmic epidemiology.

[18]  R. Klein,et al.  Genome-Wide Linkage Analyses to Identify Loci for Diabetic Retinopathy , 2007, Diabetes.

[19]  E. Boerwinkle,et al.  A Genome-Wide Linkage Scan for Diabetic Retinopathy Susceptibility Genes in Mexican Americans With Type 2 Diabetes From Starr County, Texas , 2007, Diabetes.

[20]  Barbara Eden Kobrin Klein.  Overview of Epidemiologic Studies of Diabetic Retinopathy , 2007 .

[21]  P. Ryan,et al.  Incidence and progression of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 2 , 2005, Clinical and Experimental Ophthalmology.

[22]  S. Harper,et al.  Regulation of vascular permeability by vascular endothelial growth factors. , 2002, Vascular pharmacology.

[23]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[24]  Clustering of Long-Term Complications in Families With Diabetes in the Diabetes Control and Complications Trial , 1997, Diabetes.

[25]  D. Rogers,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus , 1994 .

[26]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[27]  P. Mitchell,et al.  Update and implications from the Newcastle diabetic retinopathy study. , 1990, Australian and New Zealand journal of ophthalmology.

[28]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[29]  R. Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. , 1995, Ophthalmology.

[30]  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.